Katherine Ory

816 total citations
9 papers, 700 citations indexed

About

Katherine Ory is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Katherine Ory has authored 9 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Toxicology. Recurrent topics in Katherine Ory's work include RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Katherine Ory is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Katherine Ory collaborates with scholars based in France, Switzerland and United States. Katherine Ory's co-authors include Thierry Soussi, Yann Legros, Richard Lubin, Beata Schlichtholz, Sylvie Chevillard, Céline Levalois, Nicolas Ugolin, Philippe Vielh, Danielle D. Elliott and Adel K. El‐Naggar and has published in prestigious journals such as The EMBO Journal, Oncogene and Clinical Cancer Research.

In The Last Decade

Katherine Ory

9 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Ory France 7 447 337 146 100 92 9 700
Takesada Mori Japan 14 332 0.7× 361 1.1× 88 0.6× 35 0.3× 86 0.9× 29 799
Marissa Shrader United States 9 292 0.7× 380 1.1× 158 1.1× 30 0.3× 58 0.6× 15 628
Motokazu Suyama Japan 12 487 1.1× 433 1.3× 208 1.4× 83 0.8× 61 0.7× 31 954
Carlo Gatti Italy 14 383 0.9× 551 1.6× 325 2.2× 24 0.2× 106 1.2× 30 896
Shanhong Tang China 14 509 1.1× 516 1.5× 177 1.2× 53 0.5× 167 1.8× 30 1.1k
S Fredersdorf United Kingdom 5 578 1.3× 488 1.4× 86 0.6× 87 0.9× 51 0.6× 5 725
Kazushige Furuya Japan 13 310 0.7× 375 1.1× 146 1.0× 38 0.4× 33 0.4× 35 631
Robert P. Whitehead United States 14 527 1.2× 285 0.8× 162 1.1× 27 0.3× 33 0.4× 38 824
K. Aogi Japan 13 535 1.2× 153 0.5× 214 1.5× 30 0.3× 61 0.7× 33 770
Masanori Kanemura Japan 18 309 0.7× 415 1.2× 193 1.3× 18 0.2× 81 0.9× 37 920

Countries citing papers authored by Katherine Ory

Since Specialization
Citations

This map shows the geographic impact of Katherine Ory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Ory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Ory more than expected).

Fields of papers citing papers by Katherine Ory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Ory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Ory. The network helps show where Katherine Ory may publish in the future.

Co-authorship network of co-authors of Katherine Ory

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Ory. A scholar is included among the top collaborators of Katherine Ory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Ory. Katherine Ory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schlumberger, Martin, Sylvie Chevillard, Katherine Ory, et al.. (2011). Cancer de la thyroïde après exposition aux rayonnements ionisants. Cancer/Radiothérapie. 15(5). 394–399. 11 indexed citations
2.
Rigaud, O., Katherine Ory, Nicolas Ugolin, et al.. (2006). Transcriptional Response of Wild-Type and Ataxia Telangiectasia Lymphoblasts Following Exposure to Equitoxic doses of Ionizing Radiation. Journal of Radiation Research. 47(3/4). 259–272. 2 indexed citations
3.
Varès, Guillaume, et al.. (2004). Progesterone prevents radiation-induced apoptosis in breast cancer cells. Oncogene. 23(26). 4603–4613. 25 indexed citations
4.
Chevillard, Sylvie, Nicolas Ugolin, Philippe Vielh, et al.. (2004). Gene Expression Profiling of Differentiated Thyroid Neoplasms. Clinical Cancer Research. 10(19). 6586–6597. 99 indexed citations
5.
Lebeau, J., Pierre Fouchet, Katherine Ory, & Sylvie Chevillard. (2002). Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status.. PubMed. 22(4). 2161–6. 10 indexed citations
6.
Ory, Katherine, J. Lebeau, Céline Levalois, et al.. (2001). Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines. Breast Cancer Research and Treatment. 68(3). 187–198. 36 indexed citations
7.
Ory, Katherine, et al.. (1999). Functional analyses of a uniquep53 germline mutant (y236?) associated with a familial brain tumor syndrome. International Journal of Cancer. 82(1). 17–22. 6 indexed citations
8.
Soussi, Thierry, Yann Legros, Richard Lubin, Katherine Ory, & Beata Schlichtholz. (1994). Multifactorial analysis of p53 alteration in human cancer: A review. International Journal of Cancer. 57(1). 1–9. 312 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026